MCRB NASDAQ
Seres Therapeutics, Inc.
1W: -16.5%
1M: -46.9%
3M: -61.9%
YTD: -80.6%
1Y: -85.7%
3Y: -93.8%
5Y: -97.9%
$2.94
+0.01 (+0.34%)
Weekly Expected Move ±7.5%
$3
$3
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$2M
Revenue
+0.0% YoY
$-22M
Net Income
-126.1% YoY
$-51M
Free Cash Flow
+15.0% YoY
100.0%
Gross Margin
-2890.4%
Op. Margin
622.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-66.6%
ROA-18.3%
ROIC-87.8%
Valuation
P/E-1.2
P/B0.8
EV/EBITDA-2.6
Leverage
Debt/Equity1.64
Current Ratio2.11
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-14.22
Beneish M0.00